News
-
-
REGULATED PRESS RELEASE
bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
bioMérieux launches BIOFIRE® SPOTFIRE® molecular testing solution for pharmaceutical industry, revolutionizing mycoplasma testing with rapid, reliable, and compliant detection, enhancing quality control -
-
REGULATED PRESS RELEASE
Global Agreement Announced at G7 One Health Summit to Accelerate Access to Diagnostics and Responses to Rising Health Threats
Global One Health Diagnostics Access Compact (GO-Dx) launched at G7 Summit to enhance diagnostics access & response against health threats. Enhancing global health preparedness -
-
-
REGULATED PRESS RELEASE
bioMérieux Receives IVDR CE‑Marking for Two BIOFIRE® SPOTFIRE® Panels to Strengthen Near‑Patient Respiratory and Sore Throat Diagnostics Across Europe
bioMérieux receives IVDR CE-marking for two BIOFIRE SPOTFIRE panels enhancing near-patient respiratory and sore throat diagnostics across Europe -
-
-
